It has been shown that aberrant expression of the lncRNA SChLAP1 is associated with the development of lethal prostate cancer, whereas high expression levels of SChLAP1 in prostate cancer tissues are significantly associated with biochemical recurrence, clinical progression, and mortality [9]. Here, SCHLAP1 is linked to prostate carcinoma.